Baseline characteristics
| Total (n=534) | TVS (n=55) | No TVS (n=479) | P value | |
| Age, mean (±SD) | 70.8 (13.8) | 67.1 (12.4) | 71.3 (13.9) | 0.015 |
| Male | 48.5 | 50.9 | 48.2 | 0.706 |
| Atrial fibrillation/flutter | 74.3 | 81.8 | 73.5 | 0.180 |
| Coronary artery disease | 70 | 80 | 68.9 | 0.089 |
| Peripheral artery disease | 28.7 | 25.5 | 29 | 0.580 |
| Diabetes mellitus | 38.8 | 38.2 | 38.8 | 0.925 |
| Hypertension | 83.7 | 89.1 | 83.1 | 0.254 |
| Chronic lung disease | 33.9 | 36.4 | 33.6 | 0.683 |
| Hyperlipidaemia | 65.2 | 72.7 | 64.3 | 0.214 |
| Infective endocarditis | 4.1 | 10.9 | 3.3 | 0.007 |
| Pulmonary embolism | 6.4 | 7.3 | 6.3 | 0.771 |
| Tricuspid annulus, mm, mean (±SD) | 42 (6) | 39 (4) | 42 (6) | 0.158 |
| Significant aortic valve disease | ||||
| Severe aortic stenosis | 4.3 | 5.5 | 4.2 | 0.721 |
| Moderate/severe aortic regurgitation | 13.9 | 20 | 13.2 | 0.164 |
| Significant mitral valve disease | ||||
| Moderate/severe mitral stenosis | 2.8 | 9.1 | 2.1 | 0.013 |
| Moderate/severe mitral regurgitation | 66.5 | 72.7 | 65.8 | 0.300 |
| Significant left valvular heart disease | 42.1 | 61.8 | 39.9 | 0.002 |
| Heart failure with reduced ejection fraction | 56.4 | 41.8 | 58 | 0.002 |
| Left heart disease | 74.9 | 72.7 | 75.2 | 0.694 |
| Evidence of pulmonary hypertension | 79.8 | 80 | 79.7 | 0.965 |
| Previous cardiac pacing device | 49.6 | 38.2 | 50.9 | 0.073 |
| Previous cardiac surgery | 43.8 | 43.6 | 43.8 | 0.977 |
| Right ventricular systolic function: | 0.363 | |||
| Normal | 23 | 23.6 | 23 | |
| Mildly decreased | 25.8 | 34.5 | 24.8 | |
| Moderately decreased | 32.4 | 29.1 | 32.8 | |
| Severely decreased | 18.7 | 12.7 | 19.4 | |
| New York Heart Association functional class: | 0.688 | |||
| 3 | 3.6 | 2.9 | |
| 21.9 | 20 | 22.1 | |
| 59.4 | 65.5 | 58.7 | |
| 15.7 | 10.9 | 16.3 | |
| Right ventricular systolic pressure, mean (±SD) | 54.9 (18.9) | 51.9 (15.5) | 55.3 (19.2) | 0.414 |
TVS, tricuspid valve surgery.